Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Neoplasm Metastasis 6 Pancreatic Neoplasms 2 Lung Neoplasms 1 Lung Diseases 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Carboplatin 158 Paclitaxel 152 Bevacizumab 85 Gemcitabine 48 liposomal doxorubicin 47 Taxes 47 Topotecan 41 Cisplatin 34 pembrolizumab 33 Cyclophosphamide 28 olaparib 25 Immunoglobulin G 24 Disulfides 24 Specimen Handling 20 Docetaxel 20 Drug Therapy 19 Magnetic Resonance Spectroscopy 17 niraparib 16 Doxorubicin 16 Biopsy 15 mirvetuximab soravtansine 14 Hyperthermic Intraperitoneal Chemotherapy 13 rucaparib 12 Nivolumab 12 Cytoreduction Surgical Procedures 10 Albumin-Bound Paclitaxel 10 veliparib 9 Platinum 9 Chemotherapy, Adjuvant 9 130-nm albumin-bound paclitaxel 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fallopian Tube Neoplasms × demcizumab × Clear all

NCT01952249 2020-09-09

SIERRA

Mereo BioPharma

Phase 1 Terminated

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡